TY - JOUR
T1 - Current practice in Europe
T2 - how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey
AU - Proclemer, Alessandro
AU - Dagres, Nikolaos
AU - Marinskis, Germanas
AU - Pison, Laurent
AU - Lip, Gregory Y.H.
AU - Blomstrom-Lundqvist, Carina
AU - Scientific Initiative Committee, European Heart Rhythm Association
AU - Svendsen, Jesper Hastrup
PY - 2013/2
Y1 - 2013/2
N2 - The purpose of the EP wire is to examine the clinical practice in the management of sustained ventricular tachycardia (VT), with special focus on diagnostic and therapeutic strategies. Forty-five European centres, all members of the EHRA-EP Research network completed the questions of the survey. There was an equal distribution of centres with high, medium, and low volume of activity. The most common aetiologies were: post-myocardial infarction ischaemic heart disease (55%), followed by idiopathic dilated cardiomyopathy (18%), and idiopathic VT (11%) and others (12%). Cardiac magnetic resonance imaging was performed in more than 50% of patients in 24 centres (62.2%). Invasive electrophysiological study was performed in more than 70% of patients in 16 centres (35.6%), between 51 and 70% in 9 (20%), below 50% in 20 (44.5%). In 39 centres (86.7%), implantable cardioverter defibrillator implantation was considered in all patients with structural heart disease and left ventricular ejection fraction
AB - The purpose of the EP wire is to examine the clinical practice in the management of sustained ventricular tachycardia (VT), with special focus on diagnostic and therapeutic strategies. Forty-five European centres, all members of the EHRA-EP Research network completed the questions of the survey. There was an equal distribution of centres with high, medium, and low volume of activity. The most common aetiologies were: post-myocardial infarction ischaemic heart disease (55%), followed by idiopathic dilated cardiomyopathy (18%), and idiopathic VT (11%) and others (12%). Cardiac magnetic resonance imaging was performed in more than 50% of patients in 24 centres (62.2%). Invasive electrophysiological study was performed in more than 70% of patients in 16 centres (35.6%), between 51 and 70% in 9 (20%), below 50% in 20 (44.5%). In 39 centres (86.7%), implantable cardioverter defibrillator implantation was considered in all patients with structural heart disease and left ventricular ejection fraction
KW - Anti-Arrhythmia Agents
KW - Cardiac Imaging Techniques
KW - Cardiomyopathy, Dilated
KW - Catheter Ablation
KW - Defibrillators, Implantable
KW - Europe
KW - Female
KW - Health Care Surveys
KW - Humans
KW - Magnetic Resonance Imaging
KW - Male
KW - Myocardial Infarction
KW - Myocardial Ischemia
KW - Stroke Volume
KW - Tachycardia, Ventricular
U2 - 10.1093/europace/eus436
DO - 10.1093/europace/eus436
M3 - Journal article
C2 - 23334717
SN - 1099-5129
VL - 15
SP - 167
EP - 169
JO - EP Europace
JF - EP Europace
IS - 2
ER -